Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset
Establishing Asymchem’s first manufacturing footprint in Europe
The award recognizes powerful science–industry collaborations for social good
Subscribe To Our Newsletter & Stay Updated
